Sava Infond D.O.O. Boston Scientific Corp Transaction History
Sava Infond D.O.O.
- $640 Billion
- Q2 2025
A detailed history of Sava Infond D.O.O. transactions in Boston Scientific Corp stock. As of the latest transaction made, Sava Infond D.O.O. holds 53,870 shares of BSX stock, worth $5.55 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
53,870
Previous 47,310
13.87%
Holding current value
$5.55 Million
Previous $4.77 Billion
21.24%
% of portfolio
0.9%
Previous 0.91%
Shares
3 transactions
Others Institutions Holding BSX
# of Institutions
1,876Shares Held
1.22BCall Options Held
9.89MPut Options Held
7.29M-
Vanguard Group Inc Valley Forge, PA135MShares$13.9 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.64 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.76 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.42 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...